• Thumbnail for CD135
    CD135 (redirect from FLT3)
    receptor-type tyrosine-protein kinase FLT3, or fetal liver kinase-2 (Flk2) is a protein that in humans is encoded by the FLT3 gene. FLT3 is a cytokine receptor which...
    15 KB (1,727 words) - 02:27, 15 October 2024
  • Thumbnail for FMS-like tyrosine kinase 3 ligand
    ligand (FLT3LG) is a protein which in humans is encoded by the FLT3LG gene. Flt3 ligand (FL) is a hematopoietic four helical bundle cytokine. It is structurally...
    7 KB (724 words) - 01:47, 28 August 2024
  • Thumbnail for Gilteritinib
    the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor. It was developed by Astellas Pharma...
    8 KB (517 words) - 12:33, 5 August 2024
  • Thumbnail for Midostaurin
    for oncogenic FLT3, in combination with chemotherapy. The drug is approved for use with a companion diagnostic, the LeukoStrat CDx FLT3 Mutation Assay...
    7 KB (597 words) - 06:03, 5 July 2024
  • Thumbnail for Crenolanib
    to FLT3-ITD, FLT3-D835H and FLT3-D835Y with Kd of 0.74 nM, 0.4 nM, and 0.18 nM, respectively. Crenolanib inhibits the phosphorylation of the FLT3-ITD...
    19 KB (2,060 words) - 03:27, 3 December 2023
  • tyrosine kinase inhibitor. Its molecular target is FLT3, also known as CD135 which is a proto-oncogene. FLT3 mutations are among the most common mutations...
    18 KB (1,251 words) - 04:44, 27 June 2024
  • Thumbnail for Acute myeloid leukemia
    future. FLT3 internal tandem duplications (ITDs) have been shown to confer a poorer prognosis in AML with normal cytogenetics. Several FLT3 inhibitors...
    75 KB (7,543 words) - 03:11, 2 November 2024
  • Thumbnail for FIZ1
    FLT3 interacting zinc finger 1 is a protein that in humans is encoded by the FIZ1 gene. This gene encodes zinc finger protein, which interacts with a receptor...
    2 KB (243 words) - 14:54, 12 June 2022
  • and CSF1R also belong to this receptor class. FLT3 protein binds and is activated by the FLT3 ligand; FLT3 protein activation involves its forming dimers...
    48 KB (5,760 words) - 23:15, 2 December 2023
  • Thumbnail for Cabozantinib
    inhibitor (TKI) of c-Met (HGFR) and VEGFR2, and also inhibits AXL, RET, and FLT3. It was discovered and developed by Exelixis Inc. In November 2012, cabozantinib...
    21 KB (1,640 words) - 06:51, 18 September 2024